121 related articles for article (PubMed ID: 2354828)
1. Urinary gonadotropin fragment, a new tumor marker. III. Use in cervical and vulvar cancers.
Nam JH; Chang KC; Chambers JT; Schwartz PE; Cole LA
Gynecol Oncol; 1990 Jul; 38(1):66-70. PubMed ID: 2354828
[TBL] [Abstract][Full Text] [Related]
2. Urinary gonadotropin fragment (UGF) measurements in the diagnosis and management of ovarian cancer.
Cole LA; Nam JH
Yale J Biol Med; 1989; 62(4):367-78. PubMed ID: 2596125
[TBL] [Abstract][Full Text] [Related]
3. Urinary gonadotropin fragment, a new tumor marker. IV. Use in endometrial cancers and uterine mixed mullerian tumors.
Nam JH; Chambers JT; Schwartz PE; Cole LA
Gynecol Oncol; 1990 Dec; 39(3):352-7. PubMed ID: 2175287
[TBL] [Abstract][Full Text] [Related]
4. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
Cole LA; Wang YX; Elliott M; Latif M; Chambers JT; Chambers SK; Schwartz PE
Cancer Res; 1988 Mar; 48(5):1356-60. PubMed ID: 3342414
[TBL] [Abstract][Full Text] [Related]
5. Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system. I. Sensitivity and specificity, comparison with other markers.
Cole LA; Schwartz PE; Wang YX
Gynecol Oncol; 1988 Sep; 31(1):82-90. PubMed ID: 3044936
[TBL] [Abstract][Full Text] [Related]
6. Beta-core fragment (beta-core/UGF/UGP), a tumor marker: a 7-year report.
Cole LA; Tanaka A; Kim GS; Park SY; Koh MW; Schwartz PE; Chambers JT; Nam JH
Gynecol Oncol; 1996 Feb; 60(2):264-70. PubMed ID: 8631549
[TBL] [Abstract][Full Text] [Related]
7. Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system. II. Initial serial studies.
Wang YX; Schwartz PE; Chambers JT; Cole LA
Gynecol Oncol; 1988 Sep; 31(1):91-102. PubMed ID: 3410359
[TBL] [Abstract][Full Text] [Related]
8. Urinary gonadotropin fragment, a new tumor marker. I. Assay development and cancer specificity.
Nam JH; Cole LA; Chambers JT; Schwartz PE
Gynecol Oncol; 1990 Mar; 36(3):383-90. PubMed ID: 2318449
[TBL] [Abstract][Full Text] [Related]
9. Urinary gonadotropin fragment, a new tumor marker. II. Differentiating a benign from a malignant pelvic mass.
Cole LA; Nam JH; Chambers JT; Schwartz PE
Gynecol Oncol; 1990 Mar; 36(3):391-4. PubMed ID: 2318450
[TBL] [Abstract][Full Text] [Related]
10. Clinical applications of urinary gonadotropin peptides (UGP) in gynecologic oncology.
Schwartz PE; Cracchiolo BM; Cole LA
Anticancer Res; 1996; 16(4B):2135-9. PubMed ID: 8694533
[TBL] [Abstract][Full Text] [Related]
11. Serum squamous cell carcinoma antigen in gynecologic malignancies with special reference to cervical cancer.
Hsieh CY; Chang DY; Huang SC; Yen ML; Juang GT; Ouyang PC
Taiwan Yi Xue Hui Za Zhi; 1989 Aug; 88(8):797-800. PubMed ID: 2592943
[TBL] [Abstract][Full Text] [Related]
12. [Determination of the SCC antigen in the serum of patients with cervical cancer].
Crombach G; Würz H; Bolte A
Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):439-45. PubMed ID: 3623046
[TBL] [Abstract][Full Text] [Related]
13. [SCC (squamous cell carcinoma) antigen as a tumor marker in cervix cancers].
Geyer H; Schwörer D; Pfleiderer A
Geburtshilfe Frauenheilkd; 1989 Mar; 49(3):266-71. PubMed ID: 2721888
[TBL] [Abstract][Full Text] [Related]
14. Serum squamous cell carcinoma antigen levels in invasive cervical cancer: prediction of response and recurrence.
Rose PG; Baker S; Fournier L; Nelson BE; Hunter RE
Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):942-6. PubMed ID: 8456907
[TBL] [Abstract][Full Text] [Related]
15. Squamous cell carcinoma antigen in cervical cancer.
Borras G; Molina R; Xercavins J; Ballesta A; Iglesias X
Eur J Gynaecol Oncol; 1992; 13(5):414-8. PubMed ID: 1486921
[TBL] [Abstract][Full Text] [Related]
16. Serum concentrations of squamous cell carcinoma antigen in patients with vulvar intraepithelial neoplasia and vulvar cancer.
Hefler L; Obermair A; Tempfer C; van Houte M; Maenner G; Reinthaller A; Leodolter S; Kainz C
Int J Cancer; 1999 Jun; 84(3):299-303. PubMed ID: 10371350
[TBL] [Abstract][Full Text] [Related]
17. Urinary gonadotropin fragment measurements in patients with lung and esophageal disease.
D'Agostino RS; Cole LA; Ponn RB; Stern H; Schwartz PE
J Surg Oncol; 1992 Mar; 49(3):147-50. PubMed ID: 1548888
[TBL] [Abstract][Full Text] [Related]
18. [The importance of the SCC antigen in the diagnosis and follow-up of cervix carcinoma. A cooperative study of the Gynecologic Tumor Marker Group (GTMG)].
Crombach G; Würz H; Herrmann F; Kreienberg R; Möbus V; Schmidt-Rhode P; Sturm G; Caffier H; Kaesemann H
Dtsch Med Wochenschr; 1989 May; 114(18):700-5. PubMed ID: 2714197
[TBL] [Abstract][Full Text] [Related]
19. [Assessment of urinary beta-core fragment of hCG as a tumor marker of cervical cancer].
Kinugasa M; Nishimura R; Hasegawa K; Okamura M; Kimura A; Ohtsu F; Takeuchi K
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):188-94. PubMed ID: 1545171
[TBL] [Abstract][Full Text] [Related]
20. Squamous cell carcinoma antigen for monitoring cervical cancer.
Schmidt-Rhode P; Schulz KD; Sturm G; Häfner H; Prinz H; Künzig HJ
Int J Biol Markers; 1988; 3(2):87-94. PubMed ID: 3243981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
